~~<i id='7AE1ED4104'><strike id='7AE1ED4104'><tt id='7AE1ED4104'><pre id='7AE1ED4104'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

explore

author：explore 2025-08-19 12:15:00 - browse：7

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Woman returns to dialysis after doctors remove transplanted pig kidney

hotspot

focus

hotspot

Wikipedia

explore

hotspot

2:13FILE-TheburnedremainsofahomedestroyedbytheMarshallFireareshown,Jan.7,2022,inLouisville,Colo.OnTh

WSS

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Palantir health business leans on meeting customers’ needs

Retired US general questions alleged Putin, Prigozhin meeting

HCA discloses massive data breach affecting 11 million patients

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Leqembi, other new Alzheimer’s drugs require better biomarkers

Wikipedia

explore

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Shifting the focus from loneliness to social health

Heart attack and stroke risk calculators need revising

Ionis drug prevents swelling attacks due to hereditary angioedema

State Dept. review finds Biden bears some blame for Afghanistan failures

N.Y. state detects polio case, first in the U.S. since 2013

Supreme Court strikes down use of affirmative action

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Apple is now the first public company to be valued at $3 trillion

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

focus

Iowa House, Senate pass 6

HCA discloses massive data breach affecting 11 million patients

Oak trusses raised to roof of fire

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Petition to FDA: Get the lead out of consumer hair dyes

Study: Pain burden is higher in Black NFL players than white ones

hotspot

Wikipedia

explore

hotspot